Published in Curr Surg on March 30, 2005
An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J Clin Pathol (2007) 1.23
The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy. Eur Radiol (2011) 0.83
Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ? Ann Surg Oncol (2015) 0.82
Heterogeneity of focal breast lesions and surrounding tissue assessed by mammographic texture analysis: preliminary evidence of an association with tumor invasion and estrogen receptor status. Front Oncol (2011) 0.82
Sentinel Lymph Node Biopsy in Pure DCIS: Is It Necessary? ISRN Surg (2012) 0.81
Ductal carcinoma in situ and sentinel lymph node biopsy. J Breast Cancer (2011) 0.80
Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ? Ann Surg Oncol (2016) 0.79
Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy. Breast Cancer Res Treat (2016) 0.75
A simple model to assess the probability of invasion in ductal carcinoma in situ of the breast diagnosed by needle biopsy. Biomed Res Int (2014) 0.75
Sentinel lymph node biopsy in patients with breast ductal carcinoma in situ: Chinese experiences. Oncol Lett (2015) 0.75
The impact of sentinel lymph node biopsy and magnetic resonance imaging on important outcomes among patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr (2010) 0.75
Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy. Ann Surg Oncol (2012) 0.75
Development and evaluation of a prediction model for underestimated invasive breast cancer in women with ductal carcinoma in situ at stereotactic large core needle biopsy. PLoS One (2013) 0.75
Utilization of lymph node assessment in patients with ductal carcinoma in situ treated with lumpectomy. J Surg Res (2012) 0.75
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure. J Clin Oncol (2011) 2.78
Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients. J Clin Oncol (2005) 2.43
Assessing semantic similarity measures for the characterization of human regulatory pathways. Bioinformatics (2006) 2.29
Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic Oncology Group Study. Clin Cancer Res (2005) 2.22
Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer (2006) 2.00
The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer. Ann Surg Oncol (2008) 1.87
BRCC36 is essential for ionizing radiation-induced BRCA1 phosphorylation and nuclear foci formation. Cancer Res (2006) 1.65
Genomic alterations associated with early stages of breast tumor metastasis. Ann Surg Oncol (2008) 1.61
Standard versus pH-adjusted and lidocaine supplemented radiocolloid for patients undergoing sentinel-lymph-node mapping and biopsy for early breast cancer (PASSION-P trial): a double-blind, randomised controlled trial. Lancet Oncol (2009) 1.57
Prospective trial of voice outcomes after thyroidectomy: evaluation of patient-reported and clinician-determined voice assessments in identifying postthyroidectomy dysphonia. Surgery (2008) 1.53
Correlation of levels and patterns of genomic instability with histological grading of DCIS. Ann Surg Oncol (2007) 1.47
The impact of recurrent laryngeal neuromonitoring on multi-dimensional voice outcomes following thyroid surgery. J Surg Oncol (2011) 1.46
A gene expression signature that defines breast cancer metastases. Clin Exp Metastasis (2008) 1.34
High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics (2003) 1.27
Functional identity of genes detectable in expression profiling assays following globin mRNA reduction of peripheral blood samples. Clin Biochem (2007) 1.25
A prospective evaluation of patients undergoing surgery for the palliation of an advanced malignancy. Ann Surg Oncol (2002) 1.25
High-throughput loss of heterozygosity mapping in 26 commonly deleted regions in breast cancer. Cancer Epidemiol Biomarkers Prev (2003) 1.20
Effect of ASCO/CAP guidelines for determining ER status on molecular subtype. Ann Surg Oncol (2012) 1.14
Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women. Cancer (2011) 1.14
Development of a Bayesian classifier for breast cancer risk stratification: a feasibility study. Eplasty (2010) 1.14
Outer breast quadrants demonstrate increased levels of genomic instability. Ann Surg Oncol (2004) 1.08
Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides. Breast Cancer Res Treat (2005) 1.06
The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy. Thyroid (2006) 1.06
Proteomics of breast carcinoma. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.04
Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer. Ann Surg Oncol (2006) 1.03
Breast cancer in the personal genomics era. Curr Genomics (2010) 1.02
Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex technology. Oncol Rep (2007) 1.02
Electrical impedance scanning for the early detection of breast cancer in young women: preliminary results of a multicenter prospective clinical trial. J Clin Oncol (2005) 1.00
Lung cancer survival among black and white patients in an equal access health system. Cancer Epidemiol Biomarkers Prev (2012) 0.99
DW4TR: A Data Warehouse for Translational Research. J Biomed Inform (2011) 0.99
Performance of whole-genome amplified DNA isolated from serum and plasma on high-density single nucleotide polymorphism arrays. J Mol Diagn (2008) 0.98
Genomic instability in histologically normal breast tissues: implications for carcinogenesis. Lancet Oncol (2004) 0.98
Detecting outlier microarray arrays by correlation and percentage of outliers spots. Cancer Inform (2007) 0.98
A small bowel obstruction secondary to a Meckel's enterolith. Am Surg (2010) 0.97
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes. Breast Cancer Res (2012) 0.96
Correlations between serum monocyte chemotactic protein-1 levels, clinical prognostic factors, and HER-2/neu vaccine-related immunity in breast cancer patients. Clin Cancer Res (2006) 0.95
The evaluation of casualties from Operation Iraqi Freedom on return to the continental United States from March to June 2003. J Am Coll Surg (2005) 0.95
HYOU1/Orp150 expression in breast cancer. Med Sci Monit (2007) 0.93
Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett (2006) 0.93
Prospective study of electrical impedance scanning for identifying young women at risk for breast cancer. Breast Cancer Res Treat (2006) 0.93
Socioeconomic disparities and breast cancer hormone receptor status. Cancer Causes Control (2012) 0.92
Race and colon cancer survival in an equal-access health care system. Cancer Epidemiol Biomarkers Prev (2013) 0.92
Autologous pancreatic islet transplantation for severe trauma. N Engl J Med (2010) 0.90
Does breast tumor heterogeneity necessitate further immunohistochemical staining on surgical specimens? J Am Coll Surg (2012) 0.89
Amplification of HER2 is a marker for global genomic instability. BMC Cancer (2008) 0.88
Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization. Cancer Genet Cytogenet (2004) 0.88
Electrical impedance scanning as a new breast cancer risk stratification tool for young women. J Surg Oncol (2008) 0.88
Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas. Breast Cancer Res Treat (2004) 0.88
Socioeconomic disparities in colorectal cancer mortality in the United States, 1990-2007. J Community Health (2014) 0.87
Leukocyte DNA as surrogate for the evaluation of imprinted Loci methylation in mammary tissue DNA. PLoS One (2013) 0.87
Preoperative thyroid ultrasound in all patients undergoing parathyroidectomy? J Surg Res (2008) 0.87
A Bayesian derived network of breast pathology co-occurrence. J Biomed Inform (2008) 0.86
Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors. Breast Cancer Res Treat (2007) 0.86
Laser microdissection for gene expression profiling. Methods Mol Biol (2011) 0.86
Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer. Breast Cancer Res Treat (2012) 0.85
Significance of common hepatic artery lymph node metastases during pancreaticoduodenectomy for pancreatic head adenocarcinoma. Ann Surg Oncol (2007) 0.85
Thyroid cancer yield in patients with Graves' disease selected for surgery on the basis of cold scintiscan defects. Thyroid (2002) 0.85
Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine. Breast Cancer Res Treat (2006) 0.85
Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine. Cancer Immunol Immunother (2006) 0.85
Breast cancer screening compliance among young women in a free access healthcare system. J Surg Oncol (2008) 0.85
The Clinical Breast Care Project: an important resource in investigating environmental and genetic contributions to breast cancer in African American women. Cell Tissue Bank (2007) 0.84
Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer. Surgery (2006) 0.84
Chromosomal alterations associated with the transition from in situ to invasive breast cancer. Ann Surg Oncol (2008) 0.84
Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial. Cancer (2006) 0.83
Allelic imbalance in primary breast carcinomas and metastatic tumors of the axillary lymph nodes. Mol Cancer Res (2005) 0.83
Pain ratings by patients and their providers of radionucleotide injection for breast cancer lymphatic mapping. Pain Med (2012) 0.83
FH535 inhibited migration and growth of breast cancer cells. PLoS One (2012) 0.83
Differential gene expression in primary breast tumors associated with lymph node metastasis. Int J Breast Cancer (2011) 0.83
Colon cancer treatment: are there racial disparities in an equal-access healthcare system? Dis Colon Rectum (2014) 0.83
Racial variation in breast cancer treatment among Department of Defense beneficiaries. Cancer (2011) 0.83
Molecular changes in primary breast tumors and the Nottingham Histologic Score. Pathol Oncol Res (2009) 0.83
Colon sentinel lymph node mapping: practical surgical applications. J Am Coll Surg (2005) 0.82
Exploring human plasma proteome strategies: high efficiency in-solution digestion protocol for multi-dimensional protein identification technology. J Chromatogr A (2005) 0.82
Doing more: trends in breast cancer surgery, 2005 to 2011. Am Surg (2015) 0.81
Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy. Cancer Causes Control (2015) 0.81
Timing of critical genetic changes in human breast disease. Ann Surg Oncol (2005) 0.81
Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer. Breast Cancer Res Treat (2006) 0.81
BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance. Expert Rev Anticancer Ther (2006) 0.81
PSPHL and breast cancer in African American women: causative gene or population stratification? BMC Genet (2014) 0.80
Surveillance mammography among female Department of Defense beneficiaries: a study by race and ethnicity. Cancer (2013) 0.80
Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment. Breast Cancer Res (2013) 0.80
Electrical impedance scanning of thyroid nodules before thyroid surgery: a prospective study. Ann Surg Oncol (2005) 0.80
Molecular response of the axillary lymph node microenvironment to metastatic colonization. Clin Exp Metastasis (2014) 0.80
Biomedical informatics: development of a comprehensive data warehouse for clinical and genomic breast cancer research. Pharmacogenomics (2004) 0.80
Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes: a genotype-phenotype correlation study. BMC Med Genet (2012) 0.80
Persistent anterior mediastinal mass in a patient with Graves' disease. Am Surg (2010) 0.80
The effect of changing gamma count threshold on sentinel lymph node accuracy. Curr Surg (2005) 0.79
Molecular alterations associated with breast cancer mortality. PLoS One (2012) 0.79
Genomic instability in the breast microenvironment? A critical evaluation of the evidence. Expert Rev Mol Diagn (2009) 0.79
Caring for the wounded in Iraq--a photo essay. N Engl J Med (2004) 0.79
Racial/ethnic differences in breast cancer survival by inflammatory status and hormonal receptor status: an analysis of the Surveillance, Epidemiology, and End Results data. Cancer Causes Control (2014) 0.79
Analysis of metabolic and regulatory pathways through Gene Ontology-derived semantic similarity measures. AMIA Annu Symp Proc (2005) 0.79
Racial variation in tumor stage at diagnosis among Department of Defense beneficiaries. Cancer (2011) 0.79
Ki-67 proliferation index and gastric cancer: answers or more questions. J Surg Oncol (2010) 0.79
Prospective trial evaluating electrical impedance scanning of thyroid nodules before thyroidectomy: final results. Ann Surg (2008) 0.78